Virios Therapeutics Statistics
Total Valuation
VIRI has a market cap or net worth of $8.38 million. The enterprise value is $5.35 million.
| Market Cap | 8.38M |
| Enterprise Value | 5.35M |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, before market open.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
VIRI has 19.26 million shares outstanding. The number of shares has increased by 69.62% in one year.
| Shares Outstanding | 19.26M |
| Shares Change (YoY) | +69.62% |
| Shares Change (QoQ) | +0.89% |
| Owned by Insiders (%) | 9.71% |
| Owned by Institutions (%) | 8.09% |
| Float | 16.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.28 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.62, with zero debt.
| Current Ratio | 11.62 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -110.10% and return on invested capital (ROIC) is -143.08%.
| Return on Equity (ROE) | -110.10% |
| Return on Assets (ROA) | -100.20% |
| Return on Capital (ROIC) | -143.08% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.32M |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.91% in the last 52 weeks. The beta is 1.88, so VIRI's price volatility has been higher than the market average.
| Beta (1Y) | 1.88 |
| 52-Week Price Change | -26.91% |
| 50-Day Moving Average | 0.41 |
| 200-Day Moving Average | 0.81 |
| Relative Strength Index (RSI) | 50.36 |
| Average Volume (30 Days) | 381,790 |
Short Selling Information
The latest short interest is 217,540, so 1.13% of the outstanding shares have been sold short.
| Short Interest | 217,540 |
| Short Previous Month | 170,156 |
| Short % of Shares Out | 1.13% |
| Short % of Float | 1.30% |
| Short Ratio (days to cover) | 0.39 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -5.45M |
| Pretax Income | -5.30M |
| Net Income | -5.30M |
| EBITDA | -5.30M |
| EBIT | -5.30M |
| Earnings Per Share (EPS) | -$0.28 |
Balance Sheet
The company has $3.32 million in cash and no debt, giving a net cash position of $3.32 million or $0.17 per share.
| Cash & Cash Equivalents | 3.32M |
| Total Debt | n/a |
| Net Cash | 3.32M |
| Net Cash Per Share | $0.17 |
| Equity / Book Value | 3.81M |
| Book Value Per Share | 0.20 |
| Working Capital | 3.81M |
Cash Flow
| Operating Cash Flow | -4.87M |
| Capital Expenditures | n/a |
| Free Cash Flow | -4.87M |
| FCF Per Share | -$0.26 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VIRI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -69.62% |
| Shareholder Yield | -69.62% |
| Earnings Yield | -61.14% |
| FCF Yield | -56.23% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -28.87% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |